파인메딕스

387570KOSDAQ

55.3 / 100

Reference Date: 2026-09-08

Financial Score13.5 / 40

News Sentiment19.8 / 25

Momentum12.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 35.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

FineMedix is an innovative medical device manufacturer specializing in endoscopic instruments for digestive procedures, producing and selling domestic products such as ESD and EMR knives, injectors, and snare devices. The company has gained recognition both domestically and internationally, and is expanding its global market share through partnerships with major global firms and strategic growth initiatives.

Number of Employees

77people

Average Salary

45.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.95Industry Average 1.201.0Point

1.6x industry avg (risky)

ROE

-9.44Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

20.02Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.4% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼8739.1% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -4.8% (declining, 2yr)

Detailed News Sentiment

6 totalPositive 5Neutral 1Negative 0Average Sentiment Score 79.2

Positive
파인메딕스,해외 성장 본격화…영업 레버리지 기대-그로쓰리서치
파인메딕스의 국산화 제품이 해외 시장 점유율 확대와 지속적인 매출 성장을 이끌어 긍정적인 전망을 제공합니다.
Positive
파인메딕스, 한미 공동 R&D 참여..내시경 기반 췌장암 치료기기 개발
파인메딕스가 한미 공동 연구를 통해 췌장암 치료기기 개발에 진출함으로써 기술적 우위와 시장 경쟁력 강화가 기대된다.
Positive
파인메딕스, 복지부 주관 한미 공동 R&D 참여…70억원 규모
파인메딕스는 보건복지부 주도의 한미 공동 연구 프로젝트에 선정되어 분당서울대병원 등과 함께 70억원 규모의 R&D를 진행하며 기술 혁신과 시장 확장 기대.

Detailed Momentum

52-week position5.0Point

52w mid range (50%)

Current 6,600Won52-week high 9,20052-week low 3,900

1-month return6.0Point

1m +35.25% (strong rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-13